This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_BREAST_LOBULAR_EXALLC for full statistics.
This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_BREAST_LOBULAR_EXALLC for full statistics.
DOID EFO MESH Endpoint Browser
CD2_INSITU_BREAST_LOBULAR
breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.
429209 individuals
Apply sex-specific rule
239906
Check conditions None
239906
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
191
Check minimum number of events None
191
Include endpoints None
191
Remove individuals based on genotype QC
184
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
List of similar endpoints to Carcinoma in situ of breast, lobular based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 184 | 184 | - |
Unadjusted prevalence (%) | 0.04 | 0.08 | - |
Mean age at first event (years) | 57.43 | 57.43 | - |
Not a core endpoint, no data to show.
Not a core endpoint, no data to show.
Index endpoint: CD2_INSITU_BREAST_LOBULAR – Carcinoma in situ of breast, lobular
GWS hits:
Not a core endpoint, no data to show.
Endpoint not on priority list, no data to show.